Heart failure after a significant heart attack is a leading cause of death in humans. It often occurs over a few years; a person becomes weaker and weaker and eventually dies. There are very few preventative therapies.
At Baylor College of Medicine, a team of researchers has found a potential treatment that has shown promising results in mice.
Dr. Bert O’Malley
“In the mouse model, our team has been able to show that a molecule known as MCB-613 decreases damaging remodeling when given within hours after a myocardial infarction, thereby inhibiting the subsequent development of heart failure,” said Dr. Bert O’Malley, professor of molecular and cellular biology at Baylor and lead author of the study.